|
MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
|
Back to Search Results |
|
| Catalog Number |
VAMF2626C100TU |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Code |
Fistula (1862)
|
| Date of Event |
06/15/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
A valiant captivia stent grafts was implanted during the treatment of a penetrating aortic ulcer (pau) procedure.Per the operative notes, the patient was known to have a infected aorta at the time and before implanting the graft, the surgeon soaked the stent graft in an antibiotic called revampin.The patient was lost to follow and was not taking antibiotics to get rid of the infection. approximately 46 months post index procedure, a ct noted an aorto-eosophageal fistula (aef) and an intercostal type ii endoleak.Re -lining was performed on the same date using a new valiant captivia device due to the need for an eosophagectomy for the aef.Prior to the re-lining procedure, the new graft was soaked in an antibiotic also before implanting.Per the physician the source or cause of the infection is unknown.Per the physician, the aef was associated with the tevar procedure/device.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|